Head and Neck Squamous Cell Carcinoma

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
FDA Alert
FDA Alert
FDA Approves Pembrolizumab for Adults with Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma
07/21/2025
Kate Young
The FDA announced on June 12 that it has approved pembrolizumab for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1.
07/21/2025